Completed NA INTERVENTIONAL NCT00270946

Evaluation of Bilayered Cellular Matrix (OrCel) for the Treatment of Venous Ulcers

A Pivotal Study to Evaluate the Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (OrCel) for the Treatment of Venous Ulcers

Sponsor: Ortec International

Conditions Venous Leg Ulcer Venous Stasis Ulcer

Interventions Bilayered Cellular Matrix (OrCel)

Updated 4 times since 2017 Last updated: Dec 28, 2005 Started: Apr 30, 2002 Completion: Dec 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Venous Leg Ulcer and Venous Stasis Ulcer, this trial is completed. The trial is conducted by Ortec International and has accumulated 4 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Apr 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ortec International

Data source: Ortec International

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montgomery, United States